Albuked (KEDRION BIOPHARMA, INC.)


Welcome to the PulseAid listing for the Albuked drug offered from KEDRION BIOPHARMA, INC.. This Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
LABELER NAME / MANUFACTURER: KEDRION BIOPHARMA, INC.
NON-PROPRIETARY NAME: Albumin (Human)
SUBSTANCE NAME: ALBUMIN HUMAN
TYPE: PLASMA DERIVATIVE
PHARMA CLASS: Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1981-07-28
END MARKETING DATE: 0000-00-00


Albuked PLASMA DERIVATIVE Details:

Item DescriptionAlbuked from KEDRION BIOPHARMA, INC.
LABELER NAME: KEDRION BIOPHARMA, INC.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(g/50mL)
START MARKETING DATE: 1981-07-28
END MARKETING DATE: 0000-00-00
PRODUCT ID: 76125-783_45be8fa2-02d7-4b0b-9e9c-94a0d25a67d5
PRODUCT NDC: 76125-783
APPLICATION NUMBER: BLA101138

Other ALBUMIN HUMAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxalta US Inc.Buminate
CSL Behring AGAlbuRx
GRIFOLS USA, LLCALBUTEIN
KEDRION BIOPHARMA, INC.Albuked